These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 7204973

  • 1. Platelet-serotonin release by C3a and C5a: two independent pathways of activation.
    Meuer S, Ecker U, Hadding U, Bitter-Suermann D.
    J Immunol; 1981 Apr; 126(4):1506-9. PubMed ID: 7204973
    [Abstract] [Full Text] [Related]

  • 2. C3a induced activation and stimulus specific reversible desensitization of guinea pig platelets.
    Zanker B, Rasokat H, Hadding U, Bitter-Suermann D.
    Agents Actions Suppl; 1982 Apr; 11():147-57. PubMed ID: 6983827
    [Abstract] [Full Text] [Related]

  • 3. Demonstration of a specific C3a receptor on guinea pig platelets.
    Fukuoka Y, Hugli TE.
    J Immunol; 1988 May 15; 140(10):3496-501. PubMed ID: 3283237
    [Abstract] [Full Text] [Related]

  • 4. Low zone desensitization: a stimulus-specific control mechanism of cell response. Investigations on anaphylatoxin-induced platelet secretion.
    Meuer S, Zanker B, Hadding U, Bitter-Suermann D.
    J Exp Med; 1982 Mar 01; 155(3):698-710. PubMed ID: 6977607
    [Abstract] [Full Text] [Related]

  • 5. Comparative study on biological activities of various anaphylatoxins (C4a, C3a, C5a). Investigations on their ability to induce platelet secretion.
    Meuer S, Hugli TE, Andreatta RH, Hadding U, Bitter-Suermann D.
    Inflammation; 1981 Dec 01; 5(4):263-73. PubMed ID: 6976935
    [Abstract] [Full Text] [Related]

  • 6. Pulmonary injury induced by C3a and C5a anaphylatoxins.
    Stimler NP, Hugli TE, Bloor CM.
    Am J Pathol; 1980 Aug 01; 100(2):327-48. PubMed ID: 6967702
    [Abstract] [Full Text] [Related]

  • 7. Complement activation in platelet concentrates is surface-dependent and modulated by the platelets.
    Gyongyossy-Issa MI, McLeod E, Devine DV.
    J Lab Clin Med; 1994 Jun 01; 123(6):859-68. PubMed ID: 8201264
    [Abstract] [Full Text] [Related]

  • 8. Activation of the third complement component (C3) and C3a generation in cardiac anaphylaxis: histamine release and associated inotropic and chronotropic effects.
    del Balzo U, Polley MJ, Levi R.
    J Pharmacol Exp Ther; 1988 Sep 01; 246(3):911-6. PubMed ID: 2458450
    [Abstract] [Full Text] [Related]

  • 9. Analysis of the binding of fluorescent C5a and C3a to human peripheral blood leukocytes.
    van Epps DE, Chenoweth DE.
    J Immunol; 1984 Jun 01; 132(6):2862-7. PubMed ID: 6373920
    [Abstract] [Full Text] [Related]

  • 10. Anaphylatoxin-induced histamine release with human leukocytes: studies of C3a leukocyte binding and histamine release.
    Glovsky MM, Hugli TE, Ishizaka T, Lichtenstein LM, Erickson BW.
    J Clin Invest; 1979 Sep 01; 64(3):804-11. PubMed ID: 89118
    [Abstract] [Full Text] [Related]

  • 11. Induction of platelet aggregation by the complement-derived peptides C3a and C5a.
    Grossklaus C, Damerau B, Lemgo E, Vogt W.
    Naunyn Schmiedebergs Arch Pharmacol; 1976 Oct 01; 295(1):71-6. PubMed ID: 1004644
    [Abstract] [Full Text] [Related]

  • 12. Characterization of the C5a receptor on guinea pig platelets.
    Kretzschmar T, Kahl K, Rech K, Bautsch W, Köhl J, Bitter-Suermann D.
    Immunobiology; 1991 Nov 01; 183(5):418-32. PubMed ID: 1786990
    [Abstract] [Full Text] [Related]

  • 13. Proceedings: Effect of the complement-derived peptides C3a and C5a (anaphylatoxin) on platelets of different species, in vitro.
    Grossklaus C, Damerau B, Vogt W.
    Naunyn Schmiedebergs Arch Pharmacol; 1975 Nov 01; 287 Suppl():R59. PubMed ID: 1143463
    [No Abstract] [Full Text] [Related]

  • 14. Effect of C3a and C5a anaphylatoxins on guinea-pig isolated blood vessels.
    Marceau F, Hugli TE.
    J Pharmacol Exp Ther; 1984 Sep 01; 230(3):749-54. PubMed ID: 6332191
    [Abstract] [Full Text] [Related]

  • 15. Platelet activation: a new biological activity of guinea-pig C3a anaphylatoxin.
    Becker S, Meuer S, Hadding U, Bitter-Suermann D.
    Scand J Immunol; 1978 Sep 01; 7(2):173-80. PubMed ID: 653315
    [Abstract] [Full Text] [Related]

  • 16. Functional analysis and quantification of the complement C3 derived anaphylatoxin C3a with a monoclonal antibody.
    Burger R, Bader A, Kirschfink M, Rother U, Schrod L, Wörner I, Zilow G.
    Clin Exp Immunol; 1987 Jun 01; 68(3):703-11. PubMed ID: 3498585
    [Abstract] [Full Text] [Related]

  • 17. Mechanism of complement-mediated activation of human blood platelets in vitro: comparison of normal and paroxysmal nocturnal hemoglobinuria platelets.
    Dixon RH, Rosse WF.
    J Clin Invest; 1977 Feb 01; 59(2):360-8. PubMed ID: 833281
    [Abstract] [Full Text] [Related]

  • 18. Plasmin activity and complement activation during storage of citrated platelet concentrates.
    Bode AP, Miller DT, Newman SL, Castellani WJ, Norris HT.
    J Lab Clin Med; 1989 Jan 01; 113(1):94-102. PubMed ID: 2521240
    [Abstract] [Full Text] [Related]

  • 19. Demonstration of high-affinity binding sites for C3a anaphylatoxin on guinea-pig platelets.
    Becker S, Hadding U, Schorlemmer HU, Bitter-Suermann D.
    Scand J Immunol; 1978 Jan 01; 8(6):551-5. PubMed ID: 734357
    [Abstract] [Full Text] [Related]

  • 20. Microvascular effects of anaphylatoxins C3a and C5a.
    Björk J, Hugli TE, Smedegård G.
    J Immunol; 1985 Feb 01; 134(2):1115-9. PubMed ID: 3871207
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.